Tuesday, December 09, 2008

Bidders line up for MediGene's EndoTag Cancer drug

FRANKFURT, Dec 9 (Reuters) - Pfizer (PFE.N: Quote, Profile, Research, Stock Buzz) and Eli Lilly (LLY.N: Quote, Profile, Research, Stock Buzz) have submitted offers to buy marketing rights for MediGene's (MDGGn.DE: Quote, Profile, Research, Stock Buzz) EndoTag as the contest over the promising pancreatic cancer drug heats up, two people close to the situation said.






No comments: